Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Effect of clotrimazole on Naegleria fowleri.

Jamieson A.

J Clin Pathol. 1975 Jun;28(6):446-9.

2.

Immunization of mice against Naegleria fowleri infection.

John DT, Weik RR, Adams AC.

Infect Immun. 1977 Jun;16(3):817-20.

3.

Intranasal immunization of mice against Naegleria fowleri.

Bush LE, John DT.

J Protozool. 1988 Feb;35(1):172-6.

PMID:
3367318
4.

Comparison of Naegleria fowleri and Naegleria gruberi cultivated in the same nutrient medium.

Cline M, Marciano-Cabral F, Bradley SG.

J Protozool. 1983 May;30(2):387-91.

PMID:
6631780
5.

Susceptibility of Naegleria fowleri to delta 9-tetrahydrocannabinol.

Pringle HL, Bradley SG, Harris LS.

Antimicrob Agents Chemother. 1979 Nov;16(5):674-9.

6.

Therapeutic effect of rokitamycin in vitro and on experimental meningoencephalitis due to Naegleria fowleri.

Kim JH, Lee YJ, Sohn HJ, Song KJ, Kwon D, Kwon MH, Im KI, Shin HJ.

Int J Antimicrob Agents. 2008 Nov;32(5):411-7. doi: 10.1016/j.ijantimicag.2008.05.018. Epub 2008 Aug 30.

PMID:
18762406
7.

Clotrimazole: a review of its antifungal activity and therapeutic efficacy.

Sawyer PR, Brogden RN, Pinder RM, Speight TM, Avery.

Drugs. 1975;9(6):424-47. Review.

PMID:
1097234
8.

Protective immunity against Naegleria fowleri infection on mice immunized with the rNfa1 protein using mucosal adjuvants.

Lee J, Yoo JK, Sohn HJ, Kang HK, Kim D, Shin HJ, Kim JH.

Parasitol Res. 2015 Apr;114(4):1377-85. doi: 10.1007/s00436-015-4316-3. Epub 2015 Jan 22.

PMID:
25604672
9.

Host resistance of mice to Naegleria fowleri infections.

Reilly MF, White KL Jr, Bradley SG.

Infect Immun. 1983 Nov;42(2):645-52.

10.

Vaccination with lentiviral vector expressing the nfa1 gene confers a protective immune response to mice infected with Naegleria fowleri.

Kim JH, Sohn HJ, Lee J, Yang HJ, Chwae YJ, Kim K, Park S, Shin HJ.

Clin Vaccine Immunol. 2013 Jul;20(7):1055-60. doi: 10.1128/CVI.00210-13. Epub 2013 May 15.

11.

A comparison of bifonazole (BAY H 4502) with clotrimazole in vitro.

Shadomy S, Dixon DM, May R.

Sabouraudia. 1982 Dec;20(4):313-23.

PMID:
7157107
12.
13.

In vitro studies of a new imidazole antimycotic, bifonazole, in comparison with clotrimazole and miconazole.

Yamaguchi H, Hiratani T, Plempel M.

Arzneimittelforschung. 1983;33(4):546-51.

PMID:
6683531
14.

Naegleria fowleri: a free living amoeba of emerging medical importance.

Parija SC, Jayakeerthee SR.

J Commun Dis. 1999 Sep;31(3):153-9. Review.

PMID:
10916609
15.
16.

Growth inhibition of Naegleria fowleri by tetracycline, rifamycin, and miconazole.

Thong YH, Rowan-Kelly B, Shepherd C, Ferrante A.

Lancet. 1977 Oct 22;2(8043):876. No abstract available.

PMID:
72223
17.
18.

Effect of therapeutic chemical agents in vitro and on experimental meningoencephalitis due to Naegleria fowleri.

Kim JH, Jung SY, Lee YJ, Song KJ, Kwon D, Kim K, Park S, Im KI, Shin HJ.

Antimicrob Agents Chemother. 2008 Nov;52(11):4010-6. doi: 10.1128/AAC.00197-08. Epub 2008 Sep 2.

19.

The immune response induced by DNA vaccine expressing nfa1 gene against Naegleria fowleri.

Kim JH, Lee SH, Sohn HJ, Lee J, Chwae YJ, Park S, Kim K, Shin HJ.

Parasitol Res. 2012 Dec;111(6):2377-84. doi: 10.1007/s00436-012-3093-5. Epub 2012 Sep 7.

PMID:
22955499
20.

Intravenous infection of mice with Naegleria fowleri.

May RG, John DT.

Folia Parasitol (Praha). 1982;29(3):201-10.

PMID:
7129235

Supplemental Content

Support Center